The FDA reclassified 14 banned peptides in February 2026 — BPC-157, GHK-Cu, Thymosin Alpha-1, and more. Here’s what’s actually changing, what isn’t, and the timeline.
The 14 Banned Peptides Quietly Coming Back to Your Pharmacy
April 26, 2026